Dna Group (T.R.) Ltd (TLV: DNA)

Dna Group (T.R.) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	67.33	66.7	65.73	23.69	0.04	0.37
Cash & Short-Term Investments	67.33	66.7	65.73	23.69	0.04	0.37
Cash Growth	0.49%	1.47%	177.45%	56304.76%	-88.74%	-24.19%
Other Receivables	0.18	-	-	-	0	0
Receivables	0.18	-	-	-	0	0
Prepaid Expenses	-	0.17	0.19	0.22	-	0.01
Other Current Assets	-	0.07	0.01	-	0.04	2.81
Total Current Assets	67.51	66.94	65.93	23.91	0.08	3.2
Long-Term Investments	32.09	13.72	16.06	30.7	18.41	33.54
Total Assets	99.6	80.66	81.99	54.62	18.49	36.74
Accounts Payable	-	0.08	0.09	-	-	-
Accrued Expenses	-	0.3	0.4	0.29	1	0.45
Short-Term Debt	-	-	-	-	0.28	-
Current Unearned Revenue	0.31	0.31	0.31	-	-	-
Other Current Liabilities	0.36	-	-	-	9.26	8.1
Total Current Liabilities	0.67	0.69	0.79	0.29	10.54	8.55
Long-Term Unearned Revenue	0.63	0.79	1.09	-	-	-
Total Liabilities	1.3	1.47	1.88	0.29	10.54	8.55
Common Stock	141.42	141.09	141.09	99.35	71.86	69.64
Retained Earnings	-54.76	-73.54	-72.36	-48.82	-67.2	-47.93
Comprensive Income & Other	11.64	11.63	11.38	3.8	3.29	6.48
Total Common Equity	98.3	79.19	80.11	54.33	7.95	28.18
Shareholders' Equity	98.3	79.19	80.11	54.33	7.95	28.18
Total Liabilities & Equity	99.6	80.66	81.99	54.62	18.49	36.74
Total Debt	-	-	-	-	0.28	-
Net Cash (Debt)	67.33	66.7	65.73	23.69	-0.24	0.37
Net Cash Growth	0.49%	1.47%	177.45%	-	-	-24.19%
Net Cash Per Share	0.55	0.54	0.56	0.27	-0.01	0.01
Filing Date Shares Outstanding	123.16	123.16	123.16	119.57	87.61	30.26
Total Common Shares Outstanding	123.16	123.16	123.16	99.7	30.83	30.26
Working Capital	66.85	66.26	65.14	23.63	-10.46	-5.35
Book Value Per Share	0.80	0.64	0.65	0.54	0.26	0.93
Tangible Book Value	98.3	79.19	80.11	54.33	7.95	28.18
Tangible Book Value Per Share	0.80	0.64	0.65	0.54	0.26	0.93

Source: S&P Capital IQ. Standard template. Financial Sources.